Skip to main content
Back

YSEOP and Cabeus partner to accelerate AI-driven transformation within the Life Sciences industry

Paris, 18 June 2019 – YSEOP, a pioneer and world leader in Natural Language Generation (NLG) and artificial intelligence, is pleased to announce a strategic partnership with Cabeus, a specialized information management company enabling Life Sciences clients to unearth the full potential of their IT investments.

YSEOP has an unparalleled track record in automating report generation across industries, and is recognized for its unique capabilities to industrialize and achieve scale delivering complex and personalized report generation. As Life Sciences companies are increasingly embracing digital transformation, opportunities for AI to deliver gains in efficiency and accelerate time-to-market have become essential.

Through the partnership, YSEOP and Cabeus will leverage their respective market experience to address the specific requirements of the Life Sciences industry through a combination of NLG technology, regulatory knowledge, and delivery services.

“We, at Cabeus, envision several use cases within Life Sciences that could benefit from NLG. YSEOP has proven that their technologies can generate sophisticated and complex narratives based on data from clinical trials. For example, the solution’s ability to analyse adverse events and generate Patient Safety Narratives (PSNs) in literally seconds is going to be a game changer when it comes to automation of clinical study reports,” says Dr. V. “Bala” Balasubramanian, President and CEO of Cabeus.

“Because YSEOP’s NLG technology is being used to drive major transformation initiatives, we use agile methodologies to show value to the scientific and medical writing community, so they are confident with the process of natural language generation and the high quality of narratives being generated,” says Nishchal Sehgal, Vice President, Client Services at Cabeus.

“Our work with world leading pharmaceutical companies has already proven the benefits of using NLG technologies. We are enormously proud of the positive feedback we get from medical writers who have vetted our technology for ease of use, narrative quality, and impact it has on their daily productivity, saving time for them to focus on more strategic aspects of their roles. With Cabeus, we are making sure we can scale this potential across the Life Sciences industry”, says Emmanuel Walckenaer, CEO of YSEOP